81 related articles for article (PubMed ID: 2526212)
21. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
22. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
23. Magnitude of acute tolerance to opioids is not related to their potency.
Kissin I; Brown PT; Bradley EL
Anesthesiology; 1991 Nov; 75(5):813-6. PubMed ID: 1659255
[TBL] [Abstract][Full Text] [Related]
24. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
Kiritsy-Roy JA; Marson L; Van Loon GR
J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
[TBL] [Abstract][Full Text] [Related]
25. Tolerance and cross tolerance to morphine after chronic spinal D-Ala2-D-Leu5-enkephalin infusion.
Tseng LF
Life Sci; 1982 Sep; 31(10):987-92. PubMed ID: 6752616
[TBL] [Abstract][Full Text] [Related]
26. Opioid receptor regulation in mice.
Yoburn BC; Billings B; Duttaroy A
J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
[TBL] [Abstract][Full Text] [Related]
27. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
28. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
Welch SP; Singha AK; Dewey WL
J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070
[TBL] [Abstract][Full Text] [Related]
29. Delta and Mu receptor agonists correlate with greater depression of cardiac function than morphine sulfate in perfused rat hearts.
Vargish T; Beamer KC
Circ Shock; 1989 Mar; 27(3):245-51. PubMed ID: 2539920
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
Wagner EJ; Rønnekleiv OK; Kelly MJ
J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
[TBL] [Abstract][Full Text] [Related]
31. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
Sbacchi M; La Regina A; Petrillo P; Tavani A
NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
[TBL] [Abstract][Full Text] [Related]
32. Alternated delta and mu receptor activation: a stratagem for limiting opioid tolerance.
Russell RD; Kwen-Jen C
Pain; 1989 Mar; 36(3):381-389. PubMed ID: 2540475
[TBL] [Abstract][Full Text] [Related]
33. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat.
Yaksh TL; Noueihed RY; Durant PA
Anesthesiology; 1986 Jan; 64(1):54-66. PubMed ID: 2867722
[TBL] [Abstract][Full Text] [Related]
34. Epidural and intrathecal administration of sufentanil, alfentanil and morphine in the dog: a comparison of analgesic effects and the development of tolerance.
Tiseo PJ; Sabbe MB; Yaksh TL
NIDA Res Monogr; 1990; 105():560. PubMed ID: 1831544
[No Abstract] [Full Text] [Related]
35. Tolerance to the respiratory actions of opiates: withdrawal tolerance and asymmetrical cross-tolerance.
Ayesta FJ; Flórez J
Eur J Pharmacol; 1990 Jan; 175(1):1-12. PubMed ID: 2138980
[TBL] [Abstract][Full Text] [Related]
36. Opioid efficacy is linked to the LiCl-sensitive, inositol-1,4,5-trisphosphate-restorable pathway.
Raffa RB; Connelly CD; Martinez RP
Eur J Pharmacol; 1992 Jul; 217(2-3):221-3. PubMed ID: 1330592
[TBL] [Abstract][Full Text] [Related]
37. Tolerance development to butorphanol: comparison with morphine.
Feng YZ; Tseng YT; Jaw SP; Hoskins B; Ho IK
Pharmacol Biochem Behav; 1994 Nov; 49(3):649-55. PubMed ID: 7862720
[TBL] [Abstract][Full Text] [Related]
38. Conditioned taste preference produced by pairing a taste with a low dose of morphine or sufentanil.
Lett BT; Grant VL
Psychopharmacology (Berl); 1989; 98(2):236-9. PubMed ID: 2526955
[TBL] [Abstract][Full Text] [Related]
39. Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy.
Saeki S; Yaksh TL
Anesth Analg; 1993 Aug; 77(2):265-74. PubMed ID: 8346825
[TBL] [Abstract][Full Text] [Related]
40. Parker and Radow test of drug withdrawal aversion: opposite effect in rats chronically infused with sufentanil or amphetamine.
Mucha RF; Walker MJ; Fassos FF
Pharmacol Biochem Behav; 1990 Jan; 35(1):219-24. PubMed ID: 1969164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
